All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery Endocrinology Gastroenterology Immunology Infectious Diseases Mental Health Neurology Obstetrics Orthopedics Public Health Respiratory Rheumatology Urology Track topics on Twitter Track topics that are important to you
It was announced last month that Schlaff's company would invest $5 million in CollPlant, propelling the company's market cap up to NIS 85 million.
Original Article: Billionaire Martin Schlaff invests in CollPlant
Quick LinksAdvanced Search | Login | Subscribe | RSS
Search Biotech, Medical and Healthcare News
Popular Biotech, Medical and Healthcare News
Biotech News by Article Type
Biotech News by Location
BioPortfolio Bloggers
Publishing Your News on BioPortfolio
Recent Visitor News Searches